Xiamen Kingdomway Group Company (SHE:002626)
China · Delayed Price · Currency is CNY 16.43
+0.49 (3.07%)
Sep 14, 2026, 3:04 PM CST
SHE:002626 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,410 | 3,365 | 3,240 | 3,103 | 3,009 | 3,616 |
Revenue Growth | -1.02% | 3.87% | 4.43% | 3.10% | -16.78% | 3.19% |
Gross Profit Gross Profit Growth | 1,294 | 1,271 | 1,238 | 1,136 | 1,142 | 1,711 |
Operating Income Operating Income Growth | 464.42 | 480.89 | 448.77 | 323.35 | 396.47 | 1,007 |
Net Income Net Income Growth | 262.66 | 339.91 | 341.99 | 276.71 | 257.4 | 788.86 |
Earnings Per Share EPS Growth | 0.42 | 0.55 | 0.56 | 0.45 | 0.42 | 1.29 |
EPS Growth | -45.41% | -1.79% | 24.44% | 7.14% | -67.44% | -17.83% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Nutrition and Health Supplements Nutrition and Health Supplements Growth | 3,296 | 3,171 | 3,024 | 2,935 | 3,616 |
Pharmaceutical Raw Materials Pharmaceutical Raw Materials Growth | 64.91 | 62.88 | 72.02 | 70.79 | - |
Other Other Growth | 4.74 | 5.84 | 6.86 | 3.42 | - |
Total Total Growth | 3,365 | 3,240 | 3,103 | 3,009 | 3,616 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,712 | 2,560 | 1,343 | 910.55 | 787.35 | 769.56 |
Total Debt Total Debt Growth | 2,155 | 2,497 | 1,388 | 895.19 | 1,081 | 1,123 |
Net Cash (Debt) Net Cash Growth | -442.98 | 62.92 | -45.26 | 15.36 | -293.49 | -353.65 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.70 | 0.10 | -0.07 | 0.02 | -0.48 | -0.58 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 490.17 | 556.01 | 521.14 | 658.65 | 695.12 | 847.33 |
Capital Expenditures CapEx Growth | -572.09 | -229.55 | -364.6 | -251.79 | -161.69 | -344.56 |
Free Cash Flow Free Cash Flow Growth | -81.92 | 326.46 | 156.54 | 406.87 | 533.43 | 502.77 |
Free Cash Flow Growth | - | 108.54% | -61.52% | -23.73% | 6.10% | -29.99% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Gross Margin | 37.94% | 37.76% | 38.20% | 36.62% | 37.96% | 47.32% |
Operating Margin | 13.62% | 14.29% | 13.85% | 10.42% | 13.18% | 27.84% |
Pretax Margin | 9.72% | 11.22% | 14.49% | 10.78% | 10.33% | 25.75% |
Profit Margin | 7.70% | 10.10% | 10.55% | 8.92% | 8.55% | 21.82% |
FCF Margin | -2.40% | 9.70% | 4.83% | 13.11% | 17.73% | 13.90% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.400 | 0.400 | 0.400 | 0.200 | 0.200 | 0.600 |
Dividend Per Share Growth | 0% | 0% | 100.00% | 0% | -66.67% | 0% |
Dividend Yield | 2.46% | 2.09% | 2.79% | 1.31% | 1.04% | 2.12% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 38.31 | 35.37 | 26.93 | 35.99 | 49.10 | 24.22 |
Forward PE | 18.53 | 23.12 | 20.97 | 21.66 | 24.66 | 24.66 |
P/FCF Ratio | - | 36.83 | 58.84 | 24.48 | 23.69 | 38.01 |
PS Ratio | 2.82 | 3.57 | 2.84 | 3.21 | 4.20 | 5.28 |